Cancer Tumor Markers
What Are They?
Tumor Markers are substances (usually proteins) that are found in blood that
can help identify cancer. Many times this substance is elevated in cancer types
and this is called a cancer specific tumor marker. Your doctor may take a blood sample to look for a tumor marker, however Cancer specific markers are not generally used as a way to screen for cancer
because they are not specific or sensitive enough to make a diagnoses or determination.
How Are They Used?
Many physicians will use the cancer specific tumor marker to help them follow your disease. The tumor marker might indicate how well you are responding to treatment and following treatment it might indicate whether your cancer has returned. The cancer specific marker can help them identify how quickly the disease is changing for better or worse.
Carcinoembryonic antigen or CEA is one type of cancer-specific marker that found
by tumors that arise in the gastrointestinal system. An elevated CEA does not
imply that you have a GI cancer, because it can be shown to be elevated in
people without GI disease. Rather, a CEA is monitored because if you have GI
cancer and an elevated CEA it might indicate your cancer is growing. The
physician may ask you to undergo another scan to see if you cancer has
progressed or recurred.
Specific Antigen or PSA is a protein that only men can develop that is specific
to the prostate organ. A blood test can be used to determine a man's PSA. There
is a correlation between the rise of PSA and the development of metastatic
prostate cancer. PSA is used as a marker for following prostate cancer patients.
Antigen or CA-125 is a protein that both men and women have and is used as a
cancer specific tumor marker in ovarian and GI cancers. Scientists and doctors
are measuring women's level of CA 125 to determine if a woman is at an
increased risk for ovarian cancer. CA 125 is used to check to see if cancer has
Are They Used to Diagnose?
Tumor markers are not definitive for making diagnosis of cancer. They are one method of helping to monitor your cancer treatment, determine recurrence, and determine treatment options. Treatment options may include drugs such as chemotherapy or monoclonal antibodies. Bio-pharmaceutical companies are developing hundreds of monoclonal antibodies that are made to target specific cells in the body. Click on the link below to read more about monoclonal antibodies.
For More Information Ask Your Doctor About Tumor Markers.
Your doctor will undergo complete staging in order to
diagnose your cancer. Staging may include a biopsy, resection, a clinical
workup and additional blood tests, such as testing for tumor markers.
- Monoclonal Antibodies
Hundreds of monoclonal antibodies are being developed and are either being tested in clinical trials or are awaiting approval from the Food and Drug Administration. How do you make sense of what a monoclonal...
More Information About Cancer Research
- Primary Peritoneal Cancer: Symptoms, Diagnosis, Treatment, and Clinical Trials
Primary peritoneal cancer, or PPC, is a rare type of cancer that attacks primarily women and is often considered to be a gynecologic cancer. Its a very aggressive type of cancer and can spread quickly to...
- Cancer:: Cancer Research Charity:: Cancer Research UK
Cancer; Cancer Research; Cancer Research UK is a charity that focuses upon research with the aim to understanding and curing cancers. They attempt to take the lead in areas for which are not being fully investigated. To research...
- Cancer Research:: Cancer:: Nanoparticles
Have you heard of Nanoparticles? This article focuses upon something very exciting in the field of cancer research. I am talking about these nanoparticles not Apples nano - but for treatments and a...
No comments yet.
More by this Author
The U.S. Department of Health and Human Services Food and Drug Administration developed a procedural document Finalized October 2009 titled “Guidance for Industry -Investigator Responsibilities — Protecting...
How to Choose Between ACRP and SOCRA Certification Clinical research professionals will recognize both non-profit organizations actively recruiting members: ACRP and SOCRA. The Association of Clinical...